The p19(ARF) tumor suppressor antagonizes Mdm2 to induce p53-dependent cell
cycle arrest. Individual TKO (triple knock out) mice nullizygous for ARF,
p53, and Mdm2 develop multiple tumors at a frequency greater than those obs
erved in animals lacking both p53 and Mdm2 or p53 alone, demonstrating that
p19(ARF) can act independently of the Mdm2-p53 axis in tumor surveillance.
Reintroduction of ARF into TKO mouse embryo fibroblasts (MEFs), but not in
to those lacking both p53 and ARF, arrested the cell division cycle in the
G1 phase. Inhibition of the retinoblastoma protein had no effect on the abi
lity of ARF to arrest TKO MEFs. Thus, in the absence of Mdm2, p19(ARF) inte
racts with other targets to inhibit cell proliferation.